MedPath

Analysis of Overall Survival Rate and Cost-effectiveness of Different Integrated Traditional Chinese and Western Medicine Schemes in the Treatment of Primary Liver Cancer

Not Applicable
Completed
Conditions
Primary liver cancer
Registration Number
ITMCTR2100005396
Lead Sponsor
Hongying Zhang
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Age = 18 years; (2) No treatment before diagnosis; (3) Complete regular follow-up or examination; (4) Patients with Beijing medical insurance.

Exclusion Criteria

(1) Patients with metastatic liver cancer; (2) Pregnant or lactating women; (3) Patients with an estimated survival time of less than three months; (4) Patients with incomplete clinical information.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival rate;
Secondary Outcome Measures
NameTimeMethod
Cost-effectiveness;
© Copyright 2025. All Rights Reserved by MedPath